Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.38M | -7.48M | -8.53M | -9.15M | -9.79M |
| Total Depreciation and Amortization | 268.80K | 271.90K | 273.40K | 274.20K | 276.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.07M | 2.49M | 826.20K | 976.40K | 1.10M |
| Change in Net Operating Assets | -3.70M | -3.70M | -3.70M | -1.80M | 89.00K |
| Cash from Operations | -5.74M | -8.42M | -11.13M | -9.70M | -8.32M |
| Capital Expenditure | -6.00K | -5.70K | -5.40K | -10.90K | -16.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -5.70K | -5.40K | -10.90K | -16.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -78.80K | -85.30K | -91.80K | -87.00K | -82.20K |
| Issuance of Common Stock | 21.34M | 20.22M | 19.11M | 14.55M | 10.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.14M | -1.10M | -1.06M | -759.00K | -453.80K |
| Cash from Financing | 13.28M | 12.57M | 11.77M | 8.97M | 6.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 26.60K | 53.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.53M | 4.15M | 637.00K | -708.80K | -2.10M |